ArticleBlood cancer journal2024

Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features.

Mihir D Wechalekar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.